The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...